243 related articles for article (PubMed ID: 15150555)
1. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma.
Yin PH; Lee HC; Chau GY; Wu YT; Li SH; Lui WY; Wei YH; Liu TY; Chi CW
Br J Cancer; 2004 Jun; 90(12):2390-6. PubMed ID: 15150555
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
[TBL] [Abstract][Full Text] [Related]
3. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
Yamada S; Nomoto S; Fujii T; Kaneko T; Takeda S; Inoue S; Kanazumi N; Nakao A
Eur J Surg Oncol; 2006 Apr; 32(3):303-7. PubMed ID: 16478656
[TBL] [Abstract][Full Text] [Related]
4. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
5. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis.
Yin C; Li DY; Guo X; Cao HY; Chen YB; Zhou F; Ge NJ; Liu Y; Guo SS; Zhao Z; Yang HS; Xing JL
Ann Oncol; 2019 Jun; 30(6):953-962. PubMed ID: 30887045
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.
Hsu CC; Lee HC; Wei YH
World J Gastroenterol; 2013 Dec; 19(47):8880-6. PubMed ID: 24379611
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF
Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700
[TBL] [Abstract][Full Text] [Related]
8. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.
Okochi O; Hibi K; Uemura T; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2002 Sep; 8(9):2875-8. PubMed ID: 12231530
[TBL] [Abstract][Full Text] [Related]
9. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations of mitochondrial genome in hepatocellular carcinoma.
Yin PH; Wu CC; Lin JC; Chi CW; Wei YH; Lee HC
Mitochondrion; 2010 Mar; 10(2):174-82. PubMed ID: 20006738
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hashad DI; Elyamany AS; Salem PE
Genet Test Mol Biomarkers; 2015 Nov; 19(11):604-9. PubMed ID: 26447820
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial genome instability and mtDNA depletion in human cancers.
Lee HC; Yin PH; Lin JC; Wu CC; Chen CY; Wu CW; Chi CW; Tam TN; Wei YH
Ann N Y Acad Sci; 2005 May; 1042():109-22. PubMed ID: 15965052
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the Spectrum of Mitochondrial DNA Mutations in Hepatocellular Carcinoma Using High-Throughput Sequencing.
Yu C; Wang X; Huang L; Tong Y; Chen L; Wu H; Xia Q; Kong X
Gene Expr; 2018 May; 18(2):125-134. PubMed ID: 29463347
[TBL] [Abstract][Full Text] [Related]
14. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
[TBL] [Abstract][Full Text] [Related]
15. Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia.
Shao JY; Gao HY; Li YH; Zhang Y; Lu YY; Zeng YX
World J Gastroenterol; 2004 Jun; 10(11):1560-4. PubMed ID: 15162525
[TBL] [Abstract][Full Text] [Related]
16. Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma.
Yalçınkaya B; Tastekin D; Güzelbulut F; Akgoz M; Pençe S
Rev Assoc Med Bras (1992); 2022 Sep; 68(9):1161-1165. PubMed ID: 36228247
[TBL] [Abstract][Full Text] [Related]
17. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
[TBL] [Abstract][Full Text] [Related]
18. [Changes of the mitochondrial DNA copy number and the antioxidant system in the PBMC of hepatocellular carcinoma].
Gao Y; Nie HJ; Yang D; Ding CS; Jin M; Chen ZQ; Qiu ZG; Guo X; Chen ZL; Li JW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Jan; 32(1):1-5. PubMed ID: 27255030
[TBL] [Abstract][Full Text] [Related]
19. Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology.
Zhang R; Zhang F; Wang C; Wang S; Shiao YH; Guo Z
J Exp Clin Cancer Res; 2010 Sep; 29(1):130. PubMed ID: 20849651
[TBL] [Abstract][Full Text] [Related]
20. XRCC2 repairs mitochondrial DNA damage and fuels malignant behavior in hepatocellular carcinoma.
Zhao Z; He K; Zhang Y; Hua X; Feng M; Zhao Z; Sun Y; Jiang Y; Xia Q
Cancer Lett; 2021 Aug; 512():1-14. PubMed ID: 33964350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
